Form 4: LifeStance Health Group CEO David Bourdon Reports Stock Transactions Following RSU and PSU Vesting

LifeStance Health Group's CEO, David Bourdon, reports acquisition and disposal of common stock due to vesting of restricted stock units (RSUs) and performance-based stock units (PSUs), with shares withheld for tax obligations.

Summary

• On March 6, 2025, David Bourdon, CEO of LifeStance Health Group, acquired 348,985 shares of common stock through restricted stock units (RSUs) at $0 cost.
• On the same day, 16,767 shares were disposed of at $7.88 per share to cover tax withholding obligations related to the RSU vesting.
• On March 7, 2025, Mr. Bourdon acquired 80,906 shares through performance-based stock units (PSUs) at $0 cost.
• Also on March 7, 2025, 29,685 shares were disposed of at $7.59 per share to cover tax withholding obligations related to the PSU vesting.
• Additionally on March 7, 2025, Mr. Bourdon acquired 124,644 shares through PSUs at $0 cost.
• Finally on March 7, 2025, 42,816 shares were disposed of at $7.59 per share to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Mr. Bourdon directly owns 899,123 shares of LifeStance Health Group common stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting transactions related to executive compensation. The vesting of RSUs and PSUs is a positive sign, but the tax withholding is a neutral event.

Positives

• The vesting of RSUs and PSUs indicates that Mr. Bourdon is meeting performance metrics or time-based vesting requirements set by the company.
• The increase in share ownership aligns the CEO's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Vesting of stock options and units is a common form of executive compensation in the healthcare industry.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, especially in the healthcare sector, to incentivize executives and align their interests with shareholders.
• Companies like Teladoc Health and Amwell also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and amounts of stock-based compensation vary depending on the company's size, performance, and industry standards.

Stakeholder Impact

• The transactions reported in the Form 4 filing provide transparency to shareholders regarding the CEO's stock ownership.
• The vesting of RSUs and PSUs can be seen as a positive sign for employees, as it indicates that the company is meeting its performance goals.

Key Dates